OTCMKTS:KHRNF Khiron Life Sciences Stock Forecast, Price & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Khiron Life Sciences Corp Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.35 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) Add Compare Share Today's Range$0.34Now: $0.35▼$0.3650-Day Range$0.34MA: $0.38▼$0.4352-Week Range$0.22Now: $0.35▼$0.98Volume52,489 shsAverage Volume171,227 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestSocial Media Khiron Life Sciences Corp. develops cannabis products for medical purposes. It also provides cosmeceutical and nutraceutical products. The company was founded in 2017 and is headquartered in Toronto, Canada.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingKhiron Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $2.80, Khiron Life Sciences has a forecasted upside of 693.7% from its current price of $0.35.Amount of Analyst CoverageKhiron Life Sciences has received no research coverage in the past 90 days. Previous Next 3.7 Community Rank Outperform VotesKhiron Life Sciences has received 50 “outperform” votes. (Add your “outperform” vote.)Underperform VotesKhiron Life Sciences has received 18 “underperform” votes. (Add your “underperform” vote.)Community SentimentKhiron Life Sciences has received 73.53% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Khiron Life Sciences and other stocks. Vote “Outperform” if you believe KHRNF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe KHRNF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldKhiron Life Sciences does not currently pay a dividend.Dividend GrowthKhiron Life Sciences does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Khiron Life Sciences insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.44 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:KHRNF Previous Symbol CUSIPN/A CIKN/A Webwww.khiron.ca Phone705-527-3564Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable $0.35 0.00 (0.00 %) (As of 09/29/2020 12:00 AM ET) 30 days | 90 days | 365 days | Advanced Chart Receive KHRNF News and Ratings via Email Sign-up to receive the latest news and ratings for KHRNF and its competitors with MarketBeat's FREE daily newsletter. Khiron Life Sciences (OTCMKTS:KHRNF) Frequently Asked Questions How has Khiron Life Sciences' stock price been impacted by COVID-19? Khiron Life Sciences' stock was trading at $0.4259 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, KHRNF stock has decreased by 17.2% and is now trading at $0.3528. View which stocks have been most impacted by COVID-19. Do Wall Street analysts recommend investors buy shares of Khiron Life Sciences? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Khiron Life Sciences in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Khiron Life Sciences. What price target have analysts set for KHRNF? 1 Wall Street analysts have issued 1-year target prices for Khiron Life Sciences' shares. Their forecasts range from $2.80 to $2.80. On average, they anticipate Khiron Life Sciences' share price to reach $2.80 in the next year. This suggests a possible upside of 693.7% from the stock's current price. View analysts' price targets for Khiron Life Sciences. Are investors shorting Khiron Life Sciences? Khiron Life Sciences saw a increase in short interest in September. As of September 15th, there was short interest totaling 143,800 shares, an increase of 32.7% from the August 31st total of 108,400 shares. Based on an average daily trading volume, of 188,200 shares, the short-interest ratio is presently 0.8 days. View Khiron Life Sciences' Short Interest. Who are some of Khiron Life Sciences' key competitors? Some companies that are related to Khiron Life Sciences include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Althea Group (AGH), Applied Biosciences (APPB), Auscann Group (AC8), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cannpal Animal Therapeutics (CP1), Cansortium (CNTMF) and Charlotte's Web (CWBHF). View all competitors. Who are Khiron Life Sciences' key executives? Khiron Life Sciences' management team includes the following people: Mr. Alvaro Francisco Torres, Founder, CEO & Director (Age 40)Mr. Andres Galofre, Co-founder & VP of Bus. Devel.s (Age 37)Mr. Darren Collins, CFO & Corp. Sec. (Age 36)Dr. Paulo Vega, VP of Medical (Age 54)Mr. Chris Naprawa, Pres (Age 48) What is Khiron Life Sciences' stock symbol? Khiron Life Sciences trades on the OTCMKTS under the ticker symbol "KHRNF." How do I buy shares of Khiron Life Sciences? Shares of KHRNF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Khiron Life Sciences' stock price today? One share of KHRNF stock can currently be purchased for approximately $0.35. What is Khiron Life Sciences' official website? The official website for Khiron Life Sciences is www.khiron.ca. How can I contact Khiron Life Sciences? The company can be reached via phone at 705-527-3564. This page was last updated on 9/30/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
